APA (7th ed.) Citation

Guan, K., Liu, S., Feng, Y., Li, L., Zhu, X., Bill, N., . . . Wang, X. (2025). LP‐003, a novel high‐affinity anti‐IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double‐blind, placebo‐controlled phase 2 clinical trial. Clinical & Translational Allergy, 15(6), 1. https://doi.org/10.1002/clt2.70074

Chicago Style (17th ed.) Citation

Guan, Kai, et al. "LP‐003, a Novel High‐affinity Anti‐IgE Antibody for Inadequately Controlled Seasonal Allergic Rhinitis: A Multicenter, Randomized, Double‐blind, Placebo‐controlled Phase 2 Clinical Trial." Clinical & Translational Allergy 15, no. 6 (2025): 1. https://doi.org/10.1002/clt2.70074.

MLA (9th ed.) Citation

Guan, Kai, et al. "LP‐003, a Novel High‐affinity Anti‐IgE Antibody for Inadequately Controlled Seasonal Allergic Rhinitis: A Multicenter, Randomized, Double‐blind, Placebo‐controlled Phase 2 Clinical Trial." Clinical & Translational Allergy, vol. 15, no. 6, 2025, p. 1, https://doi.org/10.1002/clt2.70074.